|
Tangen, Catherine M; Hussain, Maha H A; Higano, Celestia S et al. (2012) Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346). J Urol 188:1164-9
|
|
Albain, Kathy S; Barlow, William E; Shak, Steven et al. (2010) Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol 11:55-65
|
|
Albain, Kathy S; Barlow, William E; Ravdin, Peter M et al. (2009) Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial. Lancet 374:2055-63
|
|
Beer, Tomasz M; Tangen, Catherine M; Bland, Lisa B et al. (2006) The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894. Cancer 107:489-96
|
|
Hutchins, Laura F; Green, Stephanie J; Ravdin, Peter M et al. (2005) Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-010 J Clin Oncol 23:8313-21
|
|
Zalupski, Mark M; Rankin, Cathryn; Ryan, James R et al. (2004) Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139. Cancer 100:818-25
|
|
Presant, C A; Wolf, W; Waluch, V et al. (2000) Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy. J Clin Oncol 18:255-61
|
|
Strickland, C J; Feigl, P; Upchurch, C et al. (1997) Improving breast self-examination compliance: a Southwest Oncology Group randomized trial of three interventions. Prev Med 26:320-32
|
|
Presant, C A; Wolf, W; Waluch, V et al. (1994) Association of intratumoral pharmacokinetics of fluorouracil with clinical response. Lancet 343:1184-7
|
|
Presant, C A; Wiseman, C; Blayney, D et al. (1990) Proposed criteria for serial evaluation of quality of life in cancer patients. J Natl Cancer Inst 82:322-3
|
Showing the most recent 10 out of 16 publications
